Hiroaki Taniguchi

Sasebo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.

Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: December 26, 2019

Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia.

Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia.

Journal: International journal of hematology

Published: April 15, 2019

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Journal: Haematologica

Published: February 12, 2019

Clinical features at transformation in adult T-cell leukemia-lymphoma with smoldering and chronic types.

Clinical features at transformation in adult T-cell leukemia-lymphoma with smoldering and chronic types.

Journal: International journal of hematology

Published: October 05, 2018

Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma.

Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma.

Journal: International journal of hematology

Published: April 08, 2018

EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.

EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.

Journal: International journal of hematology

Published: December 07, 2017

High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.

High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.

Journal: Internal medicine (Tokyo, Japan)

Published: July 19, 2017

Adult T-cell leukemia/lymphoma in donor cells responding to second allogeneic hematopoietic stem cell transplantation using unrelated cord blood: the Nagasaki Transplant Group experience.

Adult T-cell leukemia/lymphoma in donor cells responding to second allogeneic hematopoietic stem cell transplantation using unrelated cord blood: the Nagasaki Transplant Group experience.

Journal: Leukemia & lymphoma

Published: May 24, 2016

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

Journal: Blood

Published: February 09, 2016

Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3.

Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3.

Journal: Cancer science

Published: November 29, 2015

CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.

CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.

Journal: The Journal of pathology

Published: September 08, 2015

Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma

Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 05, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026